Vivani Medical, Inc.
VANINasdaqCIK 1266806HealthcareFiscal year ends Dec 31
Reports and events: 322 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2907:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-26-002024 |
| 2026-09-1616:15 ET | 8-K | 7.01 Regulation FD disclosure | 0001753926-26-001808 |
| 2026-08-1708:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-26-001536 |
| 2026-08-1316:31 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-26-001482 |
| 2026-08-1316:01 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001753926-26-001477 |
| 2026-08-0608:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-26-001349 |
| 2026-07-1608:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-26-001190 |
| 2026-07-0707:46 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-26-001144 |
| 2026-06-3008:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-26-001109 |
| 2026-06-0407:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-26-000974 |
| 2026-05-1913:01 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001753926-26-000912 |
| 2026-05-1316:25 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-26-000854 |
| 2026-05-1316:24 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001753926-26-000852 |
| 2026-04-2916:30 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001753926-26-000750 |
| 2026-03-2616:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001753926-26-000550 |
| 2026-03-2616:32 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001753926-26-000548 |
| 2026-01-2716:11 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-26-000194 |
| 2025-11-1308:10 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001753926-25-001770 |
| 2025-11-1308:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-25-001768 |
| 2025-10-2806:03 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-25-001655 |
| 2025-10-0308:41 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-001582 |
| 2025-09-1709:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-001510 |
| 2025-09-0916:21 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-25-001443 |
| 2025-09-0416:56 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-001431 |
| 2025-08-1317:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001753926-25-001330 |
| 2025-08-1316:54 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-001328 |
| 2025-08-0508:20 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-001228 |
| 2025-06-2516:28 ET | 8-K | 5.07 Shareholder vote results | 0001753926-25-001005 |
| 2025-06-1706:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-25-000966 |
| 2025-06-1108:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-25-000956 |
| 2025-05-2908:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-000898 |
| 2025-05-1316:47 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001753926-25-000794 |
| 2025-05-1316:41 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-000792 |
| 2025-04-2908:01 ET | DEF 14A | Proxy statementPeriod 2025-06-24 | 0001753926-25-000694 |
| 2025-04-1508:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-000635 |
| 2025-03-3108:45 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001753926-25-000527 |
| 2025-03-3108:40 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-25-000526 |
| 2025-03-2709:11 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-000495 |
| 2025-03-2607:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-000488 |
| 2025-03-1307:40 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-000438 |
| 2024-11-1308:41 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001753926-24-001874 |
| 2024-11-1308:36 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-24-001872 |
| 2024-10-2208:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-24-001731 |
| 2024-09-2608:46 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-24-001628 |
| 2024-09-2308:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-24-001614 |
| 2024-09-0408:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-24-001531 |
| 2024-08-1316:29 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-24-001422 |
| 2024-08-1316:20 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001753926-24-001420 |
| 2024-07-1108:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-24-001236 |
| 2024-06-2816:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001753926-24-001171 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 07:32 ET. Listed shows no prices and gives no investment advice.